e-learning
resources
Paris 2018
Monday, 17.09.2018
Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Our cases with pulmonary alveolar proteinosis
G. Okumus (Istanbul, Turkey), Z. Bingol (Istanbul, Turkey), G. Öcal (Istanbul, Turkey), E. Kiyan (Istanbul, Turkey)
Source:
International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Session:
Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Session type:
Thematic Poster
Number:
3018
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Okumus (Istanbul, Turkey), Z. Bingol (Istanbul, Turkey), G. Öcal (Istanbul, Turkey), E. Kiyan (Istanbul, Turkey). Our cases with pulmonary alveolar proteinosis. 3018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Related content which might interest you:
PAS-negative pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008
Pulmonary alveolar proteinosis
Source: Eur Respir Rev 2011; 20: 98-107
Year: 2011
Pulmonary alveolar proteinosis
Source: Eur Respir Mon; 2009: 46: 208–224
Year: 2009
Lung cysts in pulmonary alveolar proteinosis.
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018
Pulmonary alveolar proteinosis, study of 29 cases
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017
Pulmonary alveolar proteinosis: report of two cases
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019
The benefits of whole lung lavage in pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 23: 503-505
Year: 2004
The role of apoptosis in idiopathic pulmonary alveolar proteinosis
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP)
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
Pulmonary alveolar proteinosis: from classification to therapy
Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020
Year: 2020
Possible ocular involvement in pulmonary alveolar proteinosis
Source: Eur Respir J 2006; 28: 456
Year: 2006
Pulmonary alveolar proteinosis and GM/CSF antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005
Abnormal intraalveolar accumulation of surfactant proteins in adults with pulmonary alveolar proteinosis
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002
Alveolar proteinosis
Source: Annual Congress 2004 - Update on rare diffuse lung diseases
Year: 2004
Surfactant proteins in pulmonary alveolar proteinosis in adults
Source: Eur Respir J 2004; 24: 426-435
Year: 2004
Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept